ALZHEIMER'S DISEASE PSYCHOSIS
Clinical trials for ALZHEIMER'S DISEASE PSYCHOSIS explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER'S DISEASE PSYCHOSIS trials appear
Sign up with your email to follow new studies for ALZHEIMER'S DISEASE PSYCHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Year-Long test for Alzheimer's hallucination drug
Symptom relief ENROLLING_BY_INVITATIONThis study aims to check the long-term safety of a drug called ACP-204 for people with Alzheimer's disease who experience psychosis, like hallucinations or delusions. It's a 52-week follow-up for 752 adults who completed a previous trial. The main goal is to see how well people t…
Matched conditions: ALZHEIMER'S DISEASE PSYCHOSIS
Phase: PHASE3 • Sponsor: ACADIA Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:35 UTC
-
Scientists test if meals change how body handles new mental health pill
Knowledge-focused OngoingThis early-stage study aims to understand how eating food affects the way the body absorbs and processes a new extended-release medication (LY03020) being developed for schizophrenia and Alzheimer's disease psychosis. It involves 16 healthy adult volunteers who will take a single…
Matched conditions: ALZHEIMER'S DISEASE PSYCHOSIS
Phase: PHASE1 • Sponsor: Luye Pharma Group Ltd. • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC